Whalesbook
FY26 Financial Highlights
Fabtech Technologies announced strong financial results for the fiscal year ended March 31, 2026, with total income surging 28.4% year-on-year to ₹431.33 crore. The company also strengthened its future revenue outlook by maintaining a consolidated order book exceeding ₹900 crore as of March 31, 2026.
Operational and Financial Improvements
Operationally, the company significantly improved its cash flow situation. Fabtech swung to a positive operating cash flow of ₹0.48 crore in FY26, a notable turnaround from a negative ₹36.15 crore in FY25.
The company also strengthened its balance sheet by reducing current borrowings to ₹42.20 crore from ₹54.09 crore in the previous fiscal year.
Strategic Growth Drivers
These results underscore Fabtech's successful execution of its growth strategy, particularly its focus on complex, high-value projects.
Expansion into high-growth geographies like Saudi Arabia and Africa, alongside diversification into the animal health segment, are key drivers for future revenue. The company's emphasis on in-house manufacturing capabilities is expected to enhance project execution efficiency and profitability.
Key Project Wins Abroad
Fabtech Technologies has been actively expanding its international footprint, securing key contracts in strategic regions.
These include a USD 7.05 million OSD Facility project in West Africa and a USD 7.8 million Animal Vaccine project in Saudi Arabia.
A significant veterinary facility project in North Africa, valued between ₹49–52 crore, is also part of this international push.
Investor Outlook
Investors can expect increased revenue visibility due to the substantial order book. The company's strengthened global presence offers diversification benefits, reducing reliance on any single market.
Improved financial health, including positive operating cash flow and reduced debt, supports Fabtech's growth trajectory.
Potential Risks
Future performance remains subject to risks, including fluctuations in revenue, income, and cash flows. The successful implementation of its strategy and future growth levels depend on its execution capabilities.
Performance is also susceptible to broader economic conditions in India and international markets, as well as industry trends and competition.
Competitive Landscape
Fabtech operates in the engineering, procurement, and construction (EPC) sector, a domain populated by major players. Peers such as Larsen & Toubro, KNR Constructions, and PNC Infratech compete in various infrastructure and industrial segments.
Fabtech's recent focus on specialized international projects and the animal health segment differentiates its strategic direction within this competitive landscape.
Key Financial Metrics
- Consolidated Total Income grew by 28.4% from ₹335.94 Cr in FY25 to ₹431.33 Cr in FY26.
- Consolidated EBITDA saw an increase of 18.29% from ₹46.97 Cr in FY25 to ₹55.56 Cr in FY26.
- Consolidated Operating Cash Flow swung from -₹36.15 Cr in FY25 to ₹0.48 Cr in FY26.
- Consolidated Current Borrowings decreased from ₹54.09 Cr in FY25 to ₹42.20 Cr in FY26.
What to Watch
Investors will be monitoring the progress and execution of large-scale pharma and infrastructure projects in Africa. Updates on expansion and execution in Saudi Arabia for vaccine and advanced pharma projects will be key.
The timely completion of the North Africa veterinary facility targeted for Q1 FY27 will also be tracked. Continued revenue growth and market expansion initiatives in MENA, GCC, and ECO Zone markets will be important indicators.